Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients.

Authors :: Chen L
Long X
Xu Q
Tan J
Wang G
Cao Y
Wei J
Luo H
Zhu H
Huang L
Meng F
Huang L
Wang N
Zhou X
Zhao L
Chen X
Mao Z
Chen C
Li Z
Sun Z
Zhao J
Wang D
Huang G
Wang W
Zhou J
Source :: Cellular & molecular immunology [Cell Mol Immunol] 2020 Sep; Vol. 17 (9), pp. 992-994. Date of Electronic Publication: 2020 Jul 03.
Publication Year :: 2020

Subjects :: Acute Kidney Injury complications
Acute Kidney Injury mortality
Acute Kidney Injury virology
Biomarkers blood
COVID-19
Case-Control Studies
China
Coronavirus Infections complications
Coronavirus Infections mortality
Coronavirus Infections virology
Cytokine Release Syndrome complications
Cytokine Release Syndrome mortality
Cytokine Release Syndrome virology
HMGB1 Protein blood
HMGB1 Protein genetics
Humans
Intensive Care Units
Lymphocytes pathology
Lymphocytes virology
Neutrophils pathology
Neutrophils virology
Pandemics
Patient Admission
Pneumonia, Viral complications
Pneumonia, Viral mortality
Pneumonia, Viral virology
Prognosis
ROC Curve
Retrospective Studies
SARS-CoV-2
Severe Acute Respiratory Syndrome complications
Severe Acute Respiratory Syndrome mortality
Severe Acute Respiratory Syndrome virology
Shock, Septic complications
Shock, Septic mortality
Shock, Septic virology
Survival Analysis
Acute Kidney Injury diagnosis
Betacoronavirus pathogenicity
Calgranulin A blood
Calgranulin B blood
Coronavirus Infections diagnosis
Cytokine Release Syndrome diagnosis
Pneumonia, Viral diagnosis
Severe Acute Respiratory Syndrome diagnosis
Shock, Septic diagnosis

Full Text Access

Tools